Showing results (121-130 of 397) with videos related to
Sort By:
Pageof 40
European Heart Journal|September 3, 2009
The European cardiac resynchronization therapy surveyKenneth Dickstein, Nigussie Bogale, Silvia Priori, et al.Journal of the American College of Cardiology|November 16, 2004
Prognostic value of osteoprotegerin in heart failure after acute myocardial infarctionThor Ueland, Rune Jemtland, Kristin Godang, et al.European Heart Journal. Acute Cardiovascular Care|September 28, 2018
Editor's Choice- Impact of insulin-treated diabetes on cardiovascular outcomes following high-risk myocardial infarctionXavier Rossello, João Pedro Ferreira, John Jv McMurray, et al.Clinical Research in Cardiology : Official Journal of the German Cardiac Society|April 7, 2019
Mean BMI, visit-to-visit BMI variability and BMI changes during follow-up in patients with acute myocardial infarction with systolic dysfunction and/or heart failure: insights from the High-Risk Myocardial Infarction InitiativeSusan Stienen, João Pedro Ferreira, Nicolas Girerd, et al.Journal of Cardiac Failure|October 19, 2006
Mannose binding lectin and soluble Toll-like receptor 2 in heart failure following acute myocardial infarctionThor Ueland, Terje Espevik, John Kjekshus, et al.American Journal of Medical Genetics. Part A|October 22, 2008
Safety and efficacy of 22 weeks of treatment with sapropterin dihydrochloride in patients with phenylketonuriaPhillip Lee, Eileen P Treacy, Eric Crombez, et al.Cardiology Research and Practice|December 1, 2018
Croatian National Data and Comparison with European Practice: Data from the Cardiac Resynchronization Therapy Survey II Multicenter RegistrySandro Brusich, Ivan Zeljković, Nikola Pavlovic, et al.European Journal of Heart Failure|November 22, 2013
Meta-analysis of symptomatic response attributable to the pacing component of cardiac resynchronization therapyS M Afzal Sohaib, Zhongbo Chen, Zachary I Whinnett, et al.European Journal of Preventive Cardiology|February 11, 2017
Highly increased Troponin I levels following high-intensity endurance cycling may detect subclinical coronary artery disease in presumably healthy leisure sport cyclists: The North Sea Race Endurance Exercise Study (NEEDED) 2013Øyvind Skadberg, Øyunn Kleiven, Magnus Bjørkavoll-Bergseth, et al.American Heart Journal|October 12, 2010
Study design and rationale for the clinical outcomes of the STABILITY Trial (STabilization of Atherosclerotic plaque By Initiation of darapLadIb TherapY) comparing darapladib versus placebo in patients with coronary heart diseaseHarvey White, Claes Held, Ralph Stewart, et al.Pageof 40